Intellectual Property India Publishes Patent Application for 'Cytotoxic Bispecific Antibodies Binding To Dr5 And Muc16 And Uses Thereof' Filed by Immuvia Inc

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517054285 A) filed by Immuvia Inc, Waltham, U.S.A., on June 5, for 'cytotoxic bispecific antibodies binding to dr5 and muc16 and uses thereof.'

Inventor(s) include Goldmakher, Viktor, S; and Gershteyn, Iosif, M.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Bispecific binding molecules are disclosed, that bind to human MUC16 and to human death receptor 5 and can kill cancer cells expressing MUC16 and death receptor 5. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic methods for using the antibodies."...